Literature DB >> 19498318

The relation of adiponectin and tumor necrosis factor alpha levels between endothelial nitric oxide synthase, angiotensin-converting enzyme, transforming growth factor beta, and tumor necrosis factor alpha gene polymorphism in adrenal incidentalomas.

E Harman1, M Karadeniz, C Biray, A Zengi, S Cetinkalp, A G Ozgen, F Saygili, A Berdeli, C Gündüz, C Yilmaz.   

Abstract

OBJECTIVE: The aim of our study was to demonstrate demographic characteristics, presence of inflammatory markers, distribution of angiotensin-converting enzyme (ACE), tumor necrosis factor (TNF), endothelial nitric oxide synthase (eNOS) genotypes and relations among these parameters in these patients and control subjects. RESEARCH DESIGN AND METHODS: Study samples were collected from 50 patients with adrenal mass and 30 control groups. The eNOS, ACE, TNF-alpha, transforming growth factor (TGF)-beta genes polymorphisms, TNF-alpha, adiponectin levels were analysed in 50 unrelated Turkish patients with a diagnosis of adrenal incidentaloma (AI).
RESULTS: There was statistically significant difference between TNF-alpha levels of patient and controls (p=0.048). We have not detected the connection between TGF-beta, TNF-alpha, ACE, eNOS gene polymorphism with serum TNF-alpha and adiponectin levels. In this study, we demonstrated that there were significant differences for ACE genotypes in the patients when compared to the controls (p<0.05). The percentages of the ID, DD, II genotypes for ACE gene polymorphism in the patients group were 30.0, 13.0, 7.0%, respectively.
CONCLUSIONS: According to different cases of eNOS, TGF-beta, ACE, and TNF-alpha gene genotypes; no statistical significant difference was found between basal cortisol, ACTH, DHEAS, metanephrine, renin, aldosterone, normetanephrine, 17-hydroxyprogesterone, 1 mg low-dose dexamethasone suppression test-cortisol response and AI size. In this study, I/D genotype was determined to be statistically higher in ACE gene in patients with AI (p=0.014).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19498318     DOI: 10.1007/BF03345766

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  44 in total

1.  Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.

Authors:  R Rossi; L Tauchmanova; A Luciano; M Di Martino; C Battista; L Del Viscovo; V Nuzzo; G Lombardi
Journal:  J Clin Endocrinol Metab       Date:  2000-04       Impact factor: 5.958

2.  Zonal expression of endothelial nitric oxide synthase in sheep and rhesus adrenal cortex.

Authors:  J K Peterson; F Moran; A J Conley; I M Bird
Journal:  Endocrinology       Date:  2001-12       Impact factor: 4.736

3.  The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection.

Authors:  S Midorikawa; H Sanada; S Hashimoto; T Suzuki; T Watanabe
Journal:  Clin Endocrinol (Oxf)       Date:  2001-06       Impact factor: 3.478

4.  Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat.

Authors:  R Bernardini; T C Kamilaris; A E Calogero; E O Johnson; M T Gomez; P W Gold; G P Chrousos
Journal:  Endocrinology       Date:  1990-06       Impact factor: 4.736

5.  Management of the clinically inapparent adrenal mass ("incidentaloma").

Authors:  Melvin M Grumbach; Beverly M K Biller; Glenn D Braunstein; Karen K Campbell; J Aidan Carney; Paul A Godley; Emily L Harris; Joseph K T Lee; Yolanda C Oertel; Mitchell C Posner; Janet A Schlechte; H Samuel Wieand
Journal:  Ann Intern Med       Date:  2003-03-04       Impact factor: 25.391

6.  Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration.

Authors:  G M Pieper
Journal:  Diabetologia       Date:  1999-02       Impact factor: 10.122

7.  Tumor necrosis factor and interleukin-1 are potent inhibitors of angiotensin-II-induced aldosterone synthesis.

Authors:  R Natarajan; S Ploszaj; R Horton; J Nadler
Journal:  Endocrinology       Date:  1989-12       Impact factor: 4.736

8.  [The -308 and -238 Polymorphisms of the TNF-alpha Promoter Gene in Type 2 Diabetes Mellitus.].

Authors:  Hye Ryoun Kim; Mi Kyung Lee; Ae Ja Park
Journal:  Korean J Lab Med       Date:  2006-02

Review 9.  Adrenocortical cells are the site of secretion and action of insulin-like growth factors and TNF-alpha.

Authors:  R Voutilainen
Journal:  Horm Metab Res       Date:  1998 Jun-Jul       Impact factor: 2.936

10.  PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1).

Authors:  B Rigat; C Hubert; P Corvol; F Soubrier
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

View more
  4 in total

1.  The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test.

Authors:  Mariana Arruda; Emanuela Mello Ribeiro Cavalari; Marcela Pessoa de Paula; Felipe Fernandes Cordeiro de Morais; Guilherme Furtado Bilro; Maria Caroline Alves Coelho; Nathalie Anne de Oliveira E Silva de Morais; Diana Choeri; Aline Moraes; Leonardo Vieira Neto
Journal:  J Hum Hypertens       Date:  2017-11-24       Impact factor: 3.012

2.  Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis.

Authors:  Mazhar Müslüm Tuna; Narin Nasıroğlu Imga; Berçem Ayçiçek Doğan; Fatma Meriç Yılmaz; Canan Topçuoğlu; Gülhan Akbaba; Dilek Berker; Serdar Güler
Journal:  J Endocrinol Invest       Date:  2014-06-13       Impact factor: 4.256

3.  Cortisol level after dexamethasone suppression test in patients with non-functioning adrenal incidentaloma is positively associated with the duration of reactive hyperemia response on microvascular bed.

Authors:  M P de Paula; A B Moraes; M das Graças Coelho de Souza; E M R Cavalari; R C Campbell; G da Silva Fernandes; M L F Farias; L M C Mendonça; M Madeira; E Bouskela; L G Kraemer-Aguiar; L Vieira Neto
Journal:  J Endocrinol Invest       Date:  2020-07-19       Impact factor: 4.256

4.  Clinically silent adrenal adenomas - their relation to the metabolic syndrome and to GNB3 C825T gene polymorphism.

Authors:  Ivica Lazúrová; Daniela Spišáková; Hedviga Wagnerová; Viera Habalová; Ingrid Dravecká; Petrášová Darina; Ivica Drahovská; Lýdia Pundová
Journal:  Wien Klin Wochenschr       Date:  2011-10-10       Impact factor: 1.704

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.